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HCV Behavioral Health Preparation of the Racial/Ethnic Minority: Measurement Development of a HCV 
Treatment Readiness Tool in Spanish and English 
Michele M. Vella, Joseph Yozviak, D.O., Judith Lash, R.N.  
 Lehigh Valley Hospital Hepatitis Care Center  
Hepatitis C: A Background of Disparities      
Survey Participants, Survey Measures & Future 
Directions  
Participants 
 Hypothesized dimensions were based on a literature review of 
multicultural, behavioral health, and clinical variables of 
HCV populations, qualitative and quantitative  HCV 
treatment experience, and data on treatment outcomes  
 A pool of  46 items were drafted were based on studies related 
to the 4 domains including: 
 a.)Coping : items generated from the intersection of health 
disparities with psychosocial coping styles  with 
consideration to multicultural competency and HCV 
population characteristics  
 b.)Trauma: items generated from Adverse Childhood 
Experience Study to determine trauma history and trauma’s 
relationship with coping, behavioral health, and HCV 
treatment motivation (CDC, 2012; Felitti et al., 1998)  
 c.)Behavioral health: items generated from SAMHSA 
considerations of behavioral health of minority communities 
and mental health and substance use/abuse impact on HCV 
(Fireman et al., 2005; SAMHSA, 2011)  
  d.)Motivation: items generated from stages of change and 
treatment adherence n chronic disease populations (Wiley et 
al., 2000) 
 
•Online data were collected from graduate counseling  
trainees (n = 22) as a pilot study. 
• 90.9% female 







• Approximately 3.2 million persons are affected with Hepatitis C 
(HCV) in the United States (CDC, 2011)  
• It is estimated that there are 17,000 new cases of HCV every year 
though fewer than 1,000 are reported (Daniels et al., 2009)  
• HCV can persist for decades without symptoms (CDC, 2011)  
• 65%-75% of infected Americans are unaware of their infection 
(CDC, 2011)  
The Color of Disparity   
•African Americans (A.A.) are twice as likely to be infected with 
HCV compared to the general U.S. population (El-Seraq et al., 2010) 
•Though A.A. make up 12% of the U.S. population, they account for 
22% of HCV cases (El-Seraq et al., 2010)  
• Persons residing in the Commonwealth of Puerto Rico have more 
than 2 times the rate of HCV antibodies (6-10%) compared to 
persons residing in Mainland U.S. (0.9-4.3%)  (Perez et al., 2007) 
•American Indians and Alaskan Natives are 2.8 times as likely to 
develop HCV than Whites (CDC, 2011)  
HIV + HCV + Racial/Ethnic Minority = Triple Jeopardy 
• It is estimated that 30%-40% of persons infected with HIV are co-
infected with HCV (CDC, 2011)  
•HIV disproportionately affects racial/ethnic minority populations 
with complications from HCV co-infection as the leading cause of 
death amongst HIV positive individuals (Franciscus & Highleyman, 
2010)   
The Intersection of HCV, Health Disparities & Psychology  
Presented at the 
annual meeting of 
Association, 
Orlando, FL, August 
3, 2012. 
The Neuropsychiatric Burden of HCV  
•Like HIV, HCV is a neurotrophic virus that causes alterations of 
sub-cortical brain structures (Hafliger, 2008)  
• HIV & HCV co-infected individuals may suffer viral alterations on 
the sub-cortical brain areas, damage caused by hyperammonemia, 
and basilar manganese deposition due to persistent hepatic 
encephalopathy 
Behavioral Health Considerations for HCV Treatment  
•Chemotherapy agents are used to treat HCV. Persons electing 
treatment may or may not be cured of the virus. These medication 
therapies may cure up to 80% of HCV (Porter & Franciscus, 2009)  
•These medications, however, carry considerable physical and 
psychological effects including: depression, anxiety, irritability, 
tearfulness, rage, decreased frustration tolerance, 
mania/hypomania, suicidal ideation, psychosis in the absence of 
delirium (co-infected patients), cognitive dysfunction, generalized 
slowing, decreased attention span, reduced executive skills, and 
fatigue (Hafliger, 2008; Hoffman et al., 2003; Onyike et al., 2004). 
• Psychological distress may lead to discontinuation of treatment.  
Hence, pre-existing negative behavioral health symptoms (i.e., 
mental health and substance use) must be minimized before 
starting treatment. 
•Racial/ethnic minorities infected with HCV and/or HIV are likely 
to have compounded barriers to quality infectious disease and 
behavioral healthcare  that could impact treatment completion 



















•Convenience sample of HCV positive adults being 
treated at LVHN HCC, over 18 years of age, and being 
evaluated for HCV treatment from January 2012 until 
January 2013 
•Participants are clinically interviewed to record socio-
demographic characteristics including gender, age, 
race/ethnicity, employment status, education, 
knowledge of HCV, and self-report route of infection   
•After socio-demographic data are gathered the 46 item 
assessment is administered  by the LVHN HCC 
behavioral health specialist in compliance with chronic 
HCV standard of care  
•Scores are assigned to each subscale domain (0=No, 
1=Sometimes, 2=Yes) with a higher sum total equaling 
the need for increased LVHN HCC team support  
•From January 2012 until July 2012, a total of (x) HCC 
assessments have completed the assessment. 
(women/men) with a mean age of  “x” (range x-x years) 
with the following racial/ethnic groups represented: 
African American (n=2), Latino (n=), Native American 
(n=1) , Asian American (n=), and White (n=) 
•Assessments will be administered until January 2013  
whereby data analysis, construct validity and construct 
validity will be analyzed retrospectively  to determine  
 
 
